Latest News of ACLX
Arcellx (ACLX) Surged in Q3. Here's Why
Baron Funds' "Baron Health Care Fund" Q3 2024 investor letter revealed a 5.81% appreciation. The top holding, Arcellx, Inc. (NASDAQ:ACLX), a biotech company focusing on cell therapies, showed signific...
Here's Why Arcellx (ACLX) Slipped in Q2
Baron Funds' "Baron Health Care Fund" Q2 2024 investor letter reported a 2.55% decline compared to benchmarks. The fund highlighted Arcellx, Inc. (NASDAQ:ACLX) as a top pick, with significant growth p...
Insider Sale: CFO Michelle Gilson Sells 12,877 Shares of Arcellx Inc (ACLX)
Michelle Gilson, CFO of Arcellx Inc (NASDAQ:ACLX), sold 12,877 shares on June 26, 2024, now owning 6,915 shares. The biotech company focuses on cell therapies for cancer and autoimmune diseases....
-
We Think Arcellx (NASDAQ:ACLX) Can Easily Afford To Drive Business Growth
By Yahoo! Finance | 4 months agoDespite potential risks, shareholders can profit from buying a struggling business at the right price. For example, Arcellx has a long cash runway despite its negative free cash flow, indicating a goo...